Scale-Resolving Simulations of Steady and Pulsatile Flow Through Healthy and Stenotic Heart Valves.


Journal

Journal of biomechanical engineering
ISSN: 1528-8951
Titre abrégé: J Biomech Eng
Pays: United States
ID NLM: 7909584

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 07 01 2021
pubmed: 17 9 2021
medline: 28 4 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

Blood-flow downstream of stenotic and healthy aortic valves exhibits intermittent random fluctuations in the velocity field which are associated with turbulence. Such flows warrant the use of computationally demanding scale-resolving models. The aim of this work was to compute and quantify this turbulent flow in healthy and stenotic heart valves for steady and pulsatile flow conditions. Large eddy simulations (LESs) and Reynolds-averaged Navier-Stokes (RANS) simulations were used to compute the flow field at inlet Reynolds numbers of 2700 and 5400 for valves with an opening area of 70 mm2 and 175 mm2 and their projected orifice-plate type counterparts. Power spectra and turbulent kinetic energy were quantified on the centerline. Projected geometries exhibited an increased pressure-drop (>90%) and elevated turbulent kinetic energy levels (>147%). Turbulence production was an order of magnitude higher in stenotic heart valves compared to healthy valves. Pulsatile flow stabilizes flow in the acceleration phase, whereas onset of deceleration triggered (healthy valve) or amplified (stenotic valve) turbulence. Simplification of the aortic valve by projecting the orifice area should be avoided in computational fluid dynamics (CFD). RANS simulations may be used to predict the transvalvular pressure-drop, but scale-resolving models are recommended when detailed information of the flow field is required.

Identifiants

pubmed: 34529056
pii: 1119643
doi: 10.1115/1.4052459
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2022 by ASME.

Auteurs

M J M M Hoeijmakers (MJMM)

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven 5600 MB The Netherlands; Ansys Inc., Villeurbanne 69100, France.

V Morgenthaler (V)

Ansys Inc., Villeurbanne 69100, France.

M C M Rutten (MCM)

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven 5600 MB, The Netherlands.

F N van de Vosse (FN)

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven 5600 MB, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH